ClinicalTrials.govpublic full text
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
psoriatic arthritis (psa), keepsake 2, risankizumab, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 802404
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.